Literature DB >> 31250378

Reversal of Global Ischemia-Induced Cognitive Dysfunction by Delayed Inhibition of TRPM2 Ion Channels.

Robert M Dietz1,2, Ivelisse Cruz-Torres2,3, James E Orfila2,4, Olivia P Patsos2,4, Kaori Shimizu2,4, Nicholas Chalmers2,4, Guiying Deng2,4, Erika Tiemeier2,4, Nidia Quillinan2,4, Paco S Herson5,6,7.   

Abstract

Hippocampal injury and cognitive impairments are common after cardiac arrest and stroke and do not have an effective intervention despite much effort. Therefore, we developed a new approach aimed at reversing synaptic dysfunction by targeting TRPM2 channels. Cardiac arrest/cardiopulmonary resuscitation (CA/CPR) in mice was used to investigate cognitive deficits and the role of the calcium-permeable ion channel transient receptor potential-M2 (TRPM2) in ischemia-induced synaptic dysfunction. Our data indicates that absence (TRPM2-/-) or acute inhibition of TRPM2 channels with tatM2NX reduced hippocampal cell death in males only, but prevented synaptic plasticity deficits in both sexes. Remarkably, administration of tatM2NX weeks after injury reversed hippocampal plasticity and memory deficits. Finally, TRPM2-dependent activation of calcineurin-GSK3β pathway contributes to synaptic plasticity impairments. These data suggest persistent TRPM2 activity following ischemia contributes to impairments of the surviving hippocampal network and that inhibition of TRPM2 channels at chronic time points may represent a novel strategy to improve functional recovery following cerebral ischemia that is independent of neuroprotection.

Entities:  

Keywords:  Cardiac arrest; Cognitive impairment; LTP; Neurorestoration; Stroke; Synaptic plasticity

Mesh:

Substances:

Year:  2019        PMID: 31250378      PMCID: PMC6934940          DOI: 10.1007/s12975-019-00712-z

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  56 in total

1.  Tissue distribution profiles of the human TRPM cation channel family.

Authors:  Elena Fonfria; Paul R Murdock; Fiona S Cusdin; Christopher D Benham; Rosemary E Kelsell; Shaun McNulty
Journal:  J Recept Signal Transduct Res       Date:  2006       Impact factor: 2.092

2.  Modulation of NMDAR subunit expression by TRPM2 channels regulates neuronal vulnerability to ischemic cell death.

Authors:  Ishraq Alim; Lucy Teves; Rongwen Li; Yasuo Mori; Michael Tymianski
Journal:  J Neurosci       Date:  2013-10-30       Impact factor: 6.167

3.  Long-term cognitive outcomes following out-of-hospital cardiac arrest: a population-based study.

Authors:  F J Mateen; K A Josephs; M R Trenerry; M D Felmlee-Devine; A L Weaver; M Carone; R D White
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

Review 4.  Calcium, ischemia and excitotoxicity.

Authors:  Kinga Szydlowska; Michael Tymianski
Journal:  Cell Calcium       Date:  2010-02-18       Impact factor: 6.817

5.  Pro-inflammatory T-lymphocytes rapidly infiltrate into the brain and contribute to neuronal injury following cardiac arrest and cardiopulmonary resuscitation.

Authors:  Guiying Deng; Jessica Carter; Richard J Traystman; David H Wagner; Paco S Herson
Journal:  J Neuroimmunol       Date:  2014-07-22       Impact factor: 3.478

6.  Dose-dependent effects of androgens on outcome after focal cerebral ischemia in adult male mice.

Authors:  Masayoshi Uchida; Julie M Palmateer; Paco S Herson; A Courtney DeVries; Jian Cheng; Patricia D Hurn
Journal:  J Cereb Blood Flow Metab       Date:  2009-05-13       Impact factor: 6.200

7.  Extended therapeutic window of a novel peptide inhibitor of TRPM2 channels following focal cerebral ischemia.

Authors:  Takeru Shimizu; Robert M Dietz; Ivelisse Cruz-Torres; Frank Strnad; Ana K Garske; Myriam Moreno; Venugopal R Venna; Nidia Quillinan; Paco S Herson
Journal:  Exp Neurol       Date:  2016-06-15       Impact factor: 5.330

8.  Glycogen synthase kinase-3 inhibition is integral to long-term potentiation.

Authors:  Claudie Hooper; Vladimir Markevich; Florian Plattner; Richard Killick; Emma Schofield; Tobias Engel; Felix Hernandez; Brian Anderton; Kobi Rosenblum; Tim Bliss; Sam F Cooke; Jesús Avila; José J Lucas; Karl Peter Giese; John Stephenson; Simon Lovestone
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

9.  Dependence of NMDA/GSK-3β mediated metaplasticity on TRPM2 channels at hippocampal CA3-CA1 synapses.

Authors:  Yu-Feng Xie; Jillian C Belrose; Gang Lei; Michael Tymianski; Yasuo Mori; John F Macdonald; Michael F Jackson
Journal:  Mol Brain       Date:  2011-12-21       Impact factor: 4.041

10.  Sex Steroids Do Not Modulate TRPM2-Mediated Injury in Females following Middle Cerebral Artery Occlusion(1,2,3).

Authors:  Nidia Quillinan; Himmat Grewal; Jelena Klawitter; Paco S Herson
Journal:  eNeuro       Date:  2014-11-12
View more
  8 in total

1.  Characterization and Optimization of the Novel Transient Receptor Potential Melastatin 2 Antagonist tatM2NX.

Authors:  I Cruz-Torres; D S Backos; P S Herson
Journal:  Mol Pharmacol       Date:  2019-11-26       Impact factor: 4.436

2.  Pharmacological Modulation of TRPM2 Channels via PARP Pathway Leads to Neuroprotection in MPTP-induced Parkinson's Disease in Sprague Dawley Rats.

Authors:  Bhupesh Vaidya; Harpinder Kaur; Pavan Thapak; Shyam Sunder Sharma; Jitendra Narain Singh
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

Review 3.  Cerebral ischemia in the developing brain.

Authors:  Robert M Dietz; Andra L Dingman; Paco S Herson
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-29       Impact factor: 6.960

4.  Inhibition of mast cell tryptase attenuates neuroinflammation via PAR-2/p38/NFκB pathway following asphyxial cardiac arrest in rats.

Authors:  Umut Ocak; Pinar Eser Ocak; Lei Huang; Weilin Xu; Yuchun Zuo; Peng Li; Marcin Gamdzyk; Gang Zuo; Jun Mo; Guangyu Zhang; John H Zhang
Journal:  J Neuroinflammation       Date:  2020-05-04       Impact factor: 8.322

5.  TRPM2 in ischemic stroke: Structure, molecular mechanisms, and drug intervention.

Authors:  Qing Wang; Ning Liu; Yuan-Shu Ni; Jia-Mei Yang; Lin Ma; Xiao-Bing Lan; Jing Wu; Jian-Guo Niu; Jian-Qiang Yu
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

Review 6.  Advances in TRP channel drug discovery: from target validation to clinical studies.

Authors:  Ari-Pekka Koivisto; Maria G Belvisi; Rachelle Gaudet; Arpad Szallasi
Journal:  Nat Rev Drug Discov       Date:  2021-09-15       Impact factor: 112.288

7.  Functional Restoration following Global Cerebral Ischemia in Juvenile Mice following Inhibition of Transient Receptor Potential M2 (TRPM2) Ion Channels.

Authors:  Robert M Dietz; James E Orfila; Nicholas Chalmers; Crystal Minjarez; Jose Vigil; Guying Deng; Nidia Quillinan; Paco S Herson
Journal:  Neural Plast       Date:  2021-10-06       Impact factor: 3.599

Review 8.  Research progress on transient receptor potential melastatin 2 channel in nervous system diseases.

Authors:  Yingchao Ying; Peifang Jiang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-04-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.